Jennifer Gershman, PharmD, CPh
Jennifer Gershman, PharmD, CPh, received her PharmD degree from Nova Southeastern University (NSU) College of Pharmacy in 2006 and completed a 2-year drug information residency. She served as a pharmacy professor at NSUâ€™s College of Pharmacy for 6 years, managed the drug information center, and conducted medication therapy management reviews. Dr. Gershman has published research on prescription drug abuse, regulatory issues, and drug information in various scholarly journals. Additionally, she received the Sheriffâ€™s Special Recognition Award for her collaboration with the Broward, Florida Sheriffâ€™s Office to prevent prescription drug abuse through a drug disposal program. She has also presented at pharmacist and physician continuing education programs on topics that include medication errors, prescription drug abuse, and legal and regulatory issues. Dr. Gershman can be followed on Twitter @jgershman2
Study Methods, Results
Surveillance data from the CDC’s Emerging Infections Program were evaluated during 2005-2016 to assess the effects of the opioid epidemic on invasive MRSA infections.1 Individuals who inject drugs were approximately 16.3 times more likely to develop invasive MRSA infections than others.1 The 6 states examined were California (3 counties); Connecticut (statewide); Georgia (8 counties); Minnesota, New York, and Tennessee (1 county each).1 The study found that invasive MRSA from injecting drugs increased from 4.1% in 2011 to 9.2% in 2016.1 Nonsterile drug use was the most common cause of invasive MRSA infection. Study limitations include the possibility of misclassifying information regarding drug use in the medical records, and the rates are based on 2011 data since this is the only year population estimates are available for individuals who inject drugs.
MRSA Signs, Symptoms and Treatment
MRSA can cause many complications including sepsis, pneumonia, bloodstream infections, and death. Pharmacists can play an important role in educating patients on signs and symptoms of an infection on the skin that may appear as the following: red, swollen, painful, warm to the touch, full of pus or other drainage, and fever. If these MRSA symptoms appear, then patients should cover the area with a bandage, wash their hands, and contact their physician.2 Additionally, personal items such as towels, washcloths, razors, and clothing should not be shared with family members or friends, and all items should be washed thoroughly. Unfortunately, MRSA is resistant to many antibiotics. Antibiotic treatment options include Bactrim, vancomycin, ceftaroline, clindamycin, minocycline, doxycycline, and daptomycin.
Prevention strategies are key for reducing the risk of invasive MRSA infection. Community-wide education on the dangers of drug abuse and injection drug use is crucial to reducing the risk of infection. Pharmacists can recommend medication-assisted treatment programs for patients. Studies have shown that syringe services programs (SSPs) can reduce the risk of infections.3 Not all states allow the sale of needles without a prescription, as it remains a controversial issue of whether this will increase drug use. Actually, evidence demonstrates that SSPs do not increase drug use or crime.3 Many SSPs offer other prevention items and strategies such as alcohol swabs, vials of sterile water, condoms, education on safer injection practices, wound care, vaccines, and overdose prevention.
- Jackson KA, Bohm MK, Brooks JT, et al. Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs-Six Sites, 2005-2016. MMWR Morb Mortal Wkly Rep. 2018;67:625-628. DOI:http://dx.doi.org/10.15585/mmwr.mm6722a2.
- Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus (MRSA). https://www.cdc.gov/mrsa/. Accessed June 9, 2018.
- Centers for Disease Control and Prevention. Syringe services programs. https://www.cdc.gov/hiv/risk/ssps.html. Accessed June 9, 2018.